The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-06-29
DOI
10.3389/fphar.2021.698905
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Surfactant for Treatment of ARDS in COVID-19 Patient
- (2021) Moshe Heching et al. CHEST
- Expression of Surfactant protein D (SP-D) distinguishes severe pandemic influenza A(H1N1) from COVID-19
- (2021) José Alberto Choreño-Parra et al. JOURNAL OF INFECTIOUS DISEASES
- Proposal of selective wedge instillation of pulmonary surfactant for COVID-19 pneumonia based on computational fluid dynamics simulation
- (2021) Hiroko Kitaoka et al. BMC Pulmonary Medicine
- A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples
- (2021) Taruna Madan et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Coinfections with Respiratory Pathogens among COVID-19 Patients in Korea
- (2021) Kyoung Ho Roh et al. Canadian Journal of Infectious Diseases & Medical Microbiology
- Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles
- (2021) Miao-Hsi Hsieh et al. Frontiers in Immunology
- Can Prophylactic High Flow of Humidified and Warmed Filtered Air Improve Survival from Bacterial Pneumonia and SARS-CoV-2 in Elderly Individuals? The Role of Surfactant Protein A
- (2021) Ata Abbasi et al. Antioxidants
- Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury
- (2021) Francesco Cattel et al. RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
- Surfactant replacement therapy: from biological basis to current clinical practice
- (2020) Roland Hentschel et al. PEDIATRIC RESEARCH
- Decreased surfactant lipids correlate with lung function in chronic obstructive pulmonary disease (COPD)
- (2020) Christina W. Agudelo et al. PLoS One
- Ambroxol for the treatment of children with acute and chronic respiratory diseases: an overview of efficacy and safety
- (2020) Ahmad Kantar et al. MULTIDISCIPLINARY RESPIRATORY MEDICINE
- Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children
- (2020) Shupeng Jiang et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Lipid–Protein and Protein–Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis
- (2020) Olga Cañadas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens
- (2020) David Kim et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Thoughts on the alveolar phase of COVID-19
- (2020) Robert J. Mason AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting
- (2020) S. Hughes et al. CLINICAL MICROBIOLOGY AND INFECTION
- Lung Surfactant for Pulmonary Barrier Restoration in Patients With COVID-19 Pneumonia
- (2020) Ursula Mirastschijski et al. Frontiers in Medicine
- Interactions of particulate matter and pulmonary surfactant: Implications for human health
- (2020) Feifei Wang et al. ADVANCES IN COLLOID AND INTERFACE SCIENCE
- Pulmonary Surfactants: a New Therapeutic Target in Asthma
- (2020) Youngwoo Choi et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Are Serum Interleukin 6 and Surfactant Protein D Levels Associated with the Clinical Course of COVID-19?
- (2020) Buğra Kerget et al. LUNG
- Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review
- (2020) Maria Gabriella Matera et al. RESPIRATORY MEDICINE
- Severity of Coronavirus Disease 2019 (COVID-19): Does Surfactant Matter?
- (2020) Ralf Weiskirchen Frontiers in Microbiology
- Co-aerosolized Pulmonary Surfactant and Ambroxol for COVID-19 ARDS Intervention: What Are We Waiting for?
- (2020) Pradeep Kumar Frontiers in Bioengineering and Biotechnology
- Sex and SP-A2 Dependent NAD(H) Redox Alterations in Mouse Alveolar Macrophages in Response to Ozone Exposure: Potential Implications for COVID-19
- (2020) He N. Xu et al. Antioxidants
- The Importance of Redox Status in the Frame of Lifestyle Approaches and the Genetics of the Lung Innate Immune Molecules, SP-A1 and SP-A2, on Differential Outcomes of COVID-19 Infection
- (2020) Fotios Tekos et al. Antioxidants
- Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials
- (2019) Shan-Shan Meng et al. BMC Pulmonary Medicine
- Genetic causes of surfactant protein abnormalities
- (2019) Lawrence M. Nogee CURRENT OPINION IN PEDIATRICS
- Surfactant Components and Tracheal Aspirate Inflammatory Markers in Preterm Infants with Respiratory Distress Syndrome
- (2018) Giovanna Verlato et al. JOURNAL OF PEDIATRICS
- Surfactant status and respiratory outcome in premature infants receiving late surfactant treatment
- (2018) Philip L. Ballard et al. PEDIATRIC RESEARCH
- Synthetic surfactants with SP-B and SP-C analogues to enable worldwide treatment of neonatal respiratory distress syndrome and other lung diseases
- (2018) J. Johansson et al. JOURNAL OF INTERNAL MEDICINE
- Lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome
- (2016) Parker S. Woods et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Lung surfactant: Function and composition in the context of development and respiratory physiology
- (2016) Wolfgang Bernhard ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER
- Evolution of surfactant therapy for respiratory distress syndrome: past, present and future
- (2016) Smeeta Sardesai et al. PEDIATRIC RESEARCH
- Development of a Synthetic Surfactant Using a Surfactant Protein-C Peptide Analog:In VitroStudies of Surface Physical Properties
- (2016) Chong-Woo Bae et al. YONSEI MEDICAL JOURNAL
- Genetic Polymorphisms of SP-A, SP-B, and SP-D and Risk of Respiratory Distress Syndrome in Preterm Neonates
- (2016) Hong-Yu Chang et al. MEDICAL SCIENCE MONITOR
- The Molecular Era of Surfactant Biology
- (2014) Jeffrey A. Whitsett Neonatology
- Surfactant therapy: past, present and future
- (2013) Christian P. Speer et al. EARLY HUMAN DEVELOPMENT
- DrugBank 4.0: shedding new light on drug metabolism
- (2013) Vivian Law et al. NUCLEIC ACIDS RESEARCH
- Surfactant phospholipid metabolism
- (2012) Marianna Agassandian et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Asthma outcomes: Pulmonary physiology
- (2012) Robert S. Tepper et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Exogenous pulmonary surfactant for acute respiratory distress syndrome in adults: A systematic review and meta-analysis
- (2012) LI-NA ZHANG et al. Experimental and Therapeutic Medicine
- Comparative study of clinical pulmonary surfactants using atomic force microscopy
- (2011) Hong Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Ambroxol: a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhood
- (2011) Davide Paleari et al. Expert Opinion on Drug Discovery
- Genetic Disorders of Surfactant Dysfunction
- (2009) Susan E. Wert et al. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
- Ambroxol in the 21st century: pharmacological and clinical update
- (2008) Mario Malerba et al. Expert Opinion on Drug Metabolism & Toxicology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started